Navigation Links
StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals
Date:2/28/2013

s also touched a new 52-week high in its latest trading session, ending the day 1.95 percent higher at $37.10. The stock fell to an intra-day low of $36.31, while its intra-day high stood at $37.22. With the upward movement, the stock grew more than 13 percent this year, compared to a gain of 6.3 percent for the S&P 500. The stock has strong support at around $37.03, as it shows a bullish trend. The stock is trading below than its 20-day and 50-day moving averages. Sign up and have access to our free report on BMY at http://www.StockCall.com/BMY022813.pdf

Astex Pharmaceuticals traded in the range of $3.08 and $3.24 in its latest trading session and ended it at $3.19, up 1.92 percent. The stock's 52 weeks range stands at $1.57 and $3.55. Astex Pharma. is up 62.76 percent in the past 12 months, while it gained 9 percent so far this year. The stock is in a bullish mode and may find its first support level at $3.17. It is trading below its 20-day moving average of $3.29 but above its 50-day average price of $3.14. Sign up and read the complimentary report on ASTX at http://www.StockCall.com/ASTX022813.pdf

Shares of Raptor Pharma ended their previous trading session marginally lower at $4.98, down 0.40 percent. The stock lost more than 14 percent this year, in contrast to the broad market. The stock has slipped from $5.03 resistance level. It has support at around $4.87 at the moment. With its downward movement, Raptor is trading below its 20-day moving average price. The stock may touch $5.08 level in the coming trading sessions. The free report on RPTP can be downloaded by signing up now at http://www.StockCall.com/RPTP022813.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making
'/>"/>

SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. StockCall Research on Boston Scientific and Medtronic: Focus on Paroxysmal Atrial Fibrillation
2. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
3. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
4. NexGen Biomedical, Inc. Provides New Insights Into Jett Travoltas Seizure Related Death
5. Omnyx Share Their Insight on Agile Software Development for Medical Devices
6. Thomson Reuters Annual Pharmaceutical Factbook Reveals Key Insights into Current Trends
7. GlaxoSmithKline Share Their Insight on Understanding DDI With a View to Better Prediction and Control
8. Pro-Dex Provides Insight Into Fiscal 2013 Operating Plan And Preliminary Results For Fiscal 2012
9. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
10. Informex Global Pharma Sourcing 2012 Presents Key Strategies & Insight For Business Success
11. New Survey Reveals How Patients Choose Their Pharmacy; AccentHealth Garners Consumer Insights from the Waiting Room
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... The Cadence Fitness & Health Center ... by the Medical Fitness Association, a non-profit organization ... achieve their full potential. The Cadence Fitness & ... in the western suburbs and second in the ... Cadence Fitness & Health Center meets guidelines set ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... – Worldwide Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Analysis Insulin Pumps ... as insulin delivery systems especially for type ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ... $2.92 per share, net to the seller in cash, ...
Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 7th Annual Healthcare Conference on Wednesday, November 17, 2010 at ... Interested parties may access a live webcast of the ... It is recommended that listeners log on 15 minutes early ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... of its common stock held by Quiver, Inc. pursuant ... Securities and Exchange Commission (the "Offering") on August 17, ... common stock in connection with Watson,s acquisition of the ...
Cached Medicine Technology:Onyx Pharmaceuticals to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 2Watson Announces Commencement of Secondary Offering by Selling Stockholder 2
(Date:4/14/2014)... North Therapeutics, Inc., announced today a publication demonstrating ... of human red blood cells exposed to plasma ... hemolytic anemia (AIHA). The article entitled "TNT003, an ... activation induced by cold agglutinin disease patient autoantibodies" ... earlier this month. TNT003 is the murine ...
(Date:4/14/2014)... April 14In dense, urban centers around the world, many ... surrounded by tall buildings that block sunlight. And as ... jammed closer together, the darkness will only spread. ... a corrugated, translucent panel that redirects sunlight onto narrow ... and hung over the edge at an angle, where ...
(Date:4/14/2014)... professor of chemical engineering at Virginia Tech , ... analyze living cells. The long-term goal is to gain ... In his lab , Lu and his students ... events inside cells. These devices promote high sensitivity and ... cells. , Based on their record of achievements, the ...
(Date:4/14/2014)... April 2014, Perth, Australia. Drug discovery company Proteomics ... development of a companion diagnostic (CDx) test with ... , The research team authenticated the panel of ... control samples. Seven biomarkers were validated at high ... , The mass spectrometry data was then cross-validated ...
(Date:4/14/2014)... guidelines for high-risk bladder cancer, chemotherapy before or ... clinical practice. The findings are published early online ... the American Cancer Society. , Clinical trials have ... muscle-invasive bladder cancer who are given chemotherapy before ... after surgery also improves survival. To investigate the ...
Breaking Medicine News(10 mins):Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Efficient analysis of small quantity of cells improves chances to understand disease 2
... medication to treat kleptomania has failed to find any ... according to researchers at the Stanford University School of ... that some medications, including the one in the trial, ... ,More than 1.2 million people in the ...
... of acute lymphoblastic leukemia have a significantly increased risk ... // ,Acute lymphoblastic leukemia is the most common ... cases diagnosed in the United States each year. It ... survival rates for patients who receive contemporary treatments now ...
... pathway by which estradiol, the primary estrogen in humans ... aids in avoiding osteoporosis. // ,It is well ... that when the production of estrogen is reduced, as ... to radiation or chemotherapeutic drugs, bones become brittle and ...
... college students, could be as harmful as cigarettes, warns a ... water in a hookah, many youngsters feel that harmful agents ... have been found between water-pipe (hookah) usage and oral, lung ... arteries," it said quoting a report of the American Lung ...
... percentage of South Asians registered in the US National Marrow ... perforce join a long queue for matching donors. ... matching bone marrow transplant here. ,Urmi, 5, has ... transplant. She loves to play with her dolls and read ...
... cancer still remains the best way to ... During the 85th General Session of the International Association ... presented two novel, non-invasive, ultra-fast images approaches to oral ... than half of all oral cancer cases documented ...
Cached Medicine News:Health News:Study Finds No Conclusive Benefit from Treating Kleptomania 2Health News:Lymphoblastic Leukemia Survivors at Risk for Secondary Cancer 2Health News:Estradiol Guards Against Osteoporosis 2Health News:Novel Methods in Diagnosing Oral Cancer 2
... Reichert UNISTAT Bilirubinometer is ... for determining total bilirubin ... It quickly determines if ... needed by providing measurement ...
Anti-GBM IgG Assay...
... EIA Test is based on ... phase enzyme-linked immunosorbent assay. The ... anti-FSH for solid phase (microtiter ... FSH in the antibody-enzyme (horseradish ...
Enzyme immunoassay for the quantitative determination of IgG autoantibodies against type IV collagen of glomerular or alveolar basement membrane (GBM) in serum and plasma....
Medicine Products: